Print Page  |  Contact Us  |  Sign In
Karthik Krishnamurthy, DO, FAOCD
Share |

Dr. Krishnamurthy is a board-certified dermatologist and a member of the American Academy of Dermatology and was elected to serve as the National President of the American Osteopathic College of Dermatology in 2016. Dr. Krishnamurthy graduated from the University of Missouri with dual degrees in Biochemistry and Medicinal Chemistry and received his medical degree from Nova Southeastern University. After his internship at Cook County Hospital in Chicago, IL, Dr. Krishnamurthy completed his dermatology training at St. Barnabas Hospital in New York, NY, where he served as chief resident.

Dr. Krishnamurthy then joined the academic faculty as Associate Professor at the Albert Einstein College of Medicine in New York, where he served as Chief of Dermatology for Jacobi Medical Center, the largest public hospital in New York City, and created a cosmetic and laser dermatology program at Montefiore Medical Center, serving as its director. Devoted to education, he trained residents daily, and was awarded “Teacher of the Year” in 2014. Dr. Krishnamurthy’s commitment to leadership and research has been recognized by the Kenneth Burnell Research Scholarship, Intendis Research Award, Allergan Research Grant, New York Academy of Medicine and American Academy of Dermatology. Paralleling his academic pursuits, Dr. Krishnamurthy was the recipient of the 2011 Academic Dermatology Leadership Program and the 2012 Editorial Mentorship program, both granted by the American Academy of Dermatology. In addition, he serves as Editor-in-Chief of the Journal of the American Osteopathic College of Dermatology, has published in prestigious journals and texts, including the Journal of Investigative Dermatology, the Journal of the American Academy of Dermatology and Dermatologic Surgery and co-authored the textbook Emergencies in Dermatology.

Given his exposure to the varied culture, ethnicity, skin-types and demographics in New York City, Dr. Krishnamurthy is an expert in complex medical dermatology, especially psoriasis, vitiligo, auto-immune diseases (lupus) and phototherapy/excimer laser, as well as dermatologic surgery, nail surgery, earlobe repair and cosmetic/injectable/laser dermatology. He is often called upon as a media expert, contributing to the New York Times, the L.A. Times, Washington Post, WebMD, CBS News, Yahoo News, Good Housekeeping and Weather.com. He relocated to Greater Jacksonville, FL with his wife, Dr. Aneesa Krishnamurthy (Rheumatologist) and twin sons.

Updates in Dermatology

Objectives:

  1. Provide attendees with an awareness of updates in dermatology and how to implement this knowledge into daily clinical practice and patient care
  2. Change pre-, peri- and post-operative practices based on recent updates and reviews
  3. Help attendees understand emerging therapies and management strategies for dermatologic disease

Needs:

  1. New advances in dermatologic treatment
  2. New methods of diagnosis or treatment
  3. Availability of new medication(s) and indication(s)
  4. Development of new technology
  5. Advances in medical knowledge

References: 

  • Talan, Mower, Krishnadasan, etal. “Antibiotic Treatment for Uncomplicated Skin Abscess”. N Engl J Med; 2016 Mar 3.
  • Fernandez-Pineda I, Williams R, Ortega-Laureano L, Jones R. “Cardiovascular Drugs in the Treatment of Infantile Hemangioma”. World J Cardiol. 2016 Jan 26;8(1):74-80.
  • Ursini F, Grembiale RD, D’Antona L, Gallo E, D’Angelo S, Citraro R, Visca P, Olivieri I, De Sarro G, Perrotti N, Russo E. “Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis”. J Investig Derm; September 2016 Volume 136, Issue 9, Pages 1892-1894.

Core competencies: 1, 2, 3, 6, 7

Pearls in Dermatology/Rheumatology

Review of literature, studies and new drugs from the last 24 months pertinent to dermatology.

Objectives: 

  1. Recognize emerging knowledge on disease state processes and management updates in dermatology, specifically rheumatologic disease
  2. Analyze new data
  3. Apply new knowledge and integrate changes in patient care

Needs:

  1. New advances in dermatologic treatment
  2. New methods of diagnosis or treatment
  3. Availability of new medication(s) or indication(s)
  4. Development of new technology
  5. Advances in medical knowledge

References:

  • Durcan L1, Clarke WA1, Magder LS1, Petri M1. “Hydroxychloroquine Blood Levels in Systemic Lupus Erythemastosus: Clarifying Dosing Controversies and Improving Adherence”. J Rheumatol. 2016 Nov;42(11):2092-7.
  • Raaschou P, Simard, JF, Hagelberg, CA, Askling J. “Rheumatoid Arthritis, Anti-Tumor Necrosis Factor Treatment, and Risk of Squamous Cell and Basal Cell Skin Cancer: Cohort Study Based on Nationwide Prospectively Recorded Data from Sweden”. BMJ 2016;352:i262.
  • Simon TA, Thompson A, Gandhi, KK, Hochberg MC, Suissa S. “Incidence of Malignancy in Adult Patients with Rheumatoid Arthritis: a Meta-Analysys”. Arthritis Research  & Therapy 2015 17:212.

Core competencies: 1, 2, 3, 6, 7

Disclosures: Off-label: Off-label uses of drugs and investigations devices

Community Search
Sign In


Forgot your password?

Haven't registered yet?

Calendar
Latest News